Hereditary neuropathies

Journal of Clinical Neuromuscular Disease

Volumn 5, Issue 2, 2003, Pages 72-80

  Jaradeh, Safwan S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Genetics in neuropathy; Hereditary motor and sensory neuropathies; Hereditary sensory and autonomic neuropathies; Peripheral nervous system diseases

Indexed keywords

CONNEXIN 32; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEUROFILAMENT PROTEIN; PERIPHERAL MYELIN PROTEIN 22; TYROSINE KINASE RECEPTOR;

AUTONOMIC NEUROPATHY; CHROMOSOME 10Q; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 1Q; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME DUPLICATION; CHROMOSOME MAP; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DISEASE CLASSIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOTOR NERVE CONDUCTION; NERVE BIOPSY; NERVE POTENTIAL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 4644372551     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200312000-00002     Document Type: Review

References (59)

1. Dyck PJ, Chance P, Lebo R, et al. Hereditary motor and sensory neuropathies. In: Dyck PA, Thomas PK, Griffin JW, et al., eds. Peripheral Neuropathy, vol 2, 3rd ed. Philadelphia: WB Saunders; 1993:1094-1136.
2. Holmberg BH. Charcot-Marie-Tooth disease in northern Sweden: an epidemiological and clinical study. Acta Neurol Scand. 1993;87:416-422.
3. Berciano J, Combarros O, Calleja J, et al. The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve. 1989;12:302-306.
4. Kaku DA, Parry GJ, Malamut R, et al. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology. 1993;43:1806-1808.
5. Nicholson GA. Penetrance of the hereditary motor and sensory neuropathy type 1A mutation: assessment by nerve conduction studies. Neurology. 1991;41:547-552.
6. Hoogendijk JE, de Visser M, Bolhuis PA, et al. Hereditary motor and sensory neuropathy type 1: Clinical and neurographical features of the 17p duplication subtype. Muscle Nerve. 1994;17:85-90.
7. Killian JM, Tiwari PS, Jacobson S, et al. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve. 1996;19: 74-78.
8. Birouk N, Gouider R, Le Guern E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 1997;120(part 5):813-823.
9. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of the peripheral myelin protein-22 in Trembler-J mouse and Charcot-Marie-Tooth disease. Nat Genet. 1992;2:288-291.
10. Chance PF, Bird TD, Matsunami N, et al. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy I phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurology. 1992;42:2295-2299.
11. Yoshikawa H, Nishimura T, Fujimura H, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerve of patients Charcot-Marie-Tooth disease type 1A. Ann Neurol. 1994;35:445-450.
12. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med. 1993;329:96-101.
13. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol (Berl). 1995;90: 645-649.
14. Bird TD, Ott J, Giblett ER. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet. 1982;34:388-394.
15. Hayasaka K, Takada G, Ionasescu VV. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet. 1993;2:1369-1372.
16. Tachi N, Kozuka N, Ohya K, et al. Tomaculous neuropathy in Charcot-Marie-Tooth disease with myelin protein zero gene mutation. J Neurol Sci. 1997;153: 106-109.
17. Plante-Bordeneuve V, Guiochon-Mantel A, Lacroix C, et al. The Roussy-Lévy family: from the original description to the gene. Ann Neurol. 1999;46:770-773.
18. Bellone E, Di Maria E, Soriani S, et al. A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum Mutat. 1999;14:353-354.
19. Gabreels-Festen A, van Beersum S, Eshuis L, et al. Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psychiatry. 1999;66:569-574.
20. Ring HZ, Chang H, Guilbot A, et al. The human neuregulin-2 (NRG2) gene: cloning, mapping and evaluation as a candidate for the autosomal recessive form of Charcot-Marie-Tooth disease linked to 5q. Hum Genet. 1999;104:326-332.
21. Rogers T, Chandler D, Angelicheva D, et al. A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. Am J Hum Genet. 2000;67:664-671.
22. Kalaydjieva L, Nikolova A, Turnev I, et al. Hereditary motor and sensory neuropathy - LOM, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. Brain. 1998;121(part 3):399-408.
23. Yoshioka R, Dyck PJ, Chance PF. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology. 1995;46:569-571.
24. Dyck PJ, Litchy WJ, Minnerath S, et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol. 1994;35:608-615.
25. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell. 2001;105:587-597.
26. Kwon JM, Elliot JL, Yee W, et al. Assignment of a second locus for Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet. 1995;57:853-858.
27. Ionasescu V, Searby C, Sheffield VC, et al. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet. 1996;5:1373-1375.
28. Takashima H, Nakagawa M, Suehara M, et al. Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1. Neuromuscul Disord. 1999;9:368-371.
29. De Jonghe P, Mersivanova I, Nelis E, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol. 2001:245-249.
30. Chapon F, Latour P, Diraison P, et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry. 1999;66:779-782.
31. Jaradeh SS. Hereditary neuropathies. American Academy of Neurology, Course 7FC.006. Denver; 2002:169-190.
32. Hahn AF, Brown WF, Koopman WJ, et al. X-linked dominant hereditary motor and sensory neuropathy. Brain. 1990;113:1511-1525.
33. Dubourg O, Tardieu S, Birouk N, et al. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain. 2001;124:1958-1967.
34. Nicholson GA, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology. 1993;43:2558-2564.
35. Ionasescu VV, Trofatter JL, Haines JL, et al. X-linked recessive Charcot-Marie-Tooth neuropathy: clinical and genetic study. Muscle Nerve. 1992;5:368-373.
36. Baxter RV, Othmane BK, Rochelle JM, et al. Ganglio-side-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet. 2002;30:21-22.
37. Quattrone A, Gambardella A, Bono F, et al. Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology. 1996;46:1318-1324.
38. Bolino A, Brancolini V, Bono F, et al. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet. 1996;5:1051-1054.
39. Guilbot A, Williams A, Ravise N, et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet. 2001;10:415-421.
40. Windebank AJ. Inherited recurrent focal neuropathies. In: Dyck PA, Thomas PK, Griffin JW, et al., eds. Peripheral Neuropathy, vol 2, 3rd ed. Philadelphia, WB Saunders; 1993:1137-1148.
41. Amato AA, Gronseth GS, Callerame KJ, et al. Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve. 1996;19:16-22.
42. Sellman MS, Mayer RF. Conduction block in hereditary neuropathy with susceptibility to pressure palsics. Muscle Nerve. 1987;10:621-625.
43. Chance PF, Abbas N, Lensch MW, et al. Two autosomal dominant neuropathies result from reciprocal duplication/deletion of a region of chromosome 17. Hum Mol Genet. 1994;3:223-228.
44. Pellegrino JE, George RA, Biegef J, et al. Hereditary neuralgic amyotrophy: evidence for genetic homogeneity and mapping to chromosome 17q25. Hum Genet. 1997;101:277-283.
45. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.
46. Ionasescu VV, Ionasescu R, Searby C. Screening of dominantly inherited Charcot-Marie-Tooth neuropathics. Muscle Nerve. 1993;16:1232-1238.
47. Jaradeh SS. Hereditary neuropathies: clinical and electrodiagnostic features and rationale testing. American Association of Electrodiagnostic Medicine Course E. San Diego; 1997:23-27.
48. Dyck PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PA, Thomas PK, Griffin JW, et al., eds. Peripheral Neuropathy, vol 2, 3rd ed. Philadelphia: WB Saunders; 1993:1065-1093
49. Nicholson GA, Dawkins JL, Blair IP, et al. The gene for hereditary sensory neuropathy type I (HSN-I) maps to chromosome 9q22.1-q22.3. Nat Genet. 1996;13:101-104.
50. Dawkins JL, Hulme DJ, Brahmbhatt SB, et al. Mutations in SPTLC1, encoding scrine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001;27:309-312.
51. Davar G, Shalish C, Blumenfeld A, et al. Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type II. Pain. 1996; 67:135-139.
52. Brunt PW, McKusick VA. Familial dysautonomia: a report of genetic and clinical studies, with a review of the literature. Medicine (Baltimore). 1970;49: 343-374.
53. Axelrod FB, Iyer K, Fish I, et al. Progressive sensory loss in familial dysautonomia. Pediatrics. 1981;67: 517-522.
54. Axelrod FB, Pearson J. Congenital sensory neuropathies. Diagnostic distinction from familial dysautonomia. Am J Dis Child. 1984;138:947-954.
55. Slaugenhaupt SA, Blumenfeld A, Liebert CB, et al. The human gene for neurotrophic tyrosine kinase receptor type 2 (NTRK2) is located on chromosome 9 but is not the familial dysautonomia gene. Genomics. 1995;25:730-732.
56. Chadwick BP, Mull J, Helbling LA, et al. Cloning, mapping, and expression of two novel actin genes, actin-like-7A (ACTL7A) and actin-like-7B (ACTL7B), from the familial dysautonomia candidate region on 9q31. Genomics. 1999;58:302-309.
57. Rafel E, Alberca R, Bautista J, et al. Congenital insensitivity to pain with anhidrosis. Muscle Nerve. 1980;3:216-220.
58. Mardy S, Miura Y, Endo F, et al. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet. 1999; 64:1570-1579.
59. Mardy S, Miura Y, Endo F, et al. Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. Hum Mol Genet. 2001;10:179-188.